Tag: Obesity Peptides

Posted on by

Mazdutide as a Dual GLP-1/GCGR Agonist: Minto Pyramid Overview of Mechanisms, Clinical Efficacy, and Metabolic Impacts

3D scientific illustration of dual GLP-1 and glucagon receptor agonist Mazdutide molecular interactions

A structured Minto Pyramid analysis of Mazdutide (IBI362), detailing its dual GLP-1 and glucagon receptor agonism, glycemic and weight regulation, and hepa

Read more Mazdutide as a Dual GLP-1/GCGR Agonist: Minto Pyramid Overview of Mechanisms, Clinical Efficacy, and Metabolic Impacts

Posted on by

Mazdutide (IBI362): Mechanisms, Clinical Data, and Metabolic Profile of Dual GLP-1/Glucagon Receptor Agonism

3D molecular visualization of Mazdutide dual GLP-1 and glucagon receptor agonist interaction.

An evidence-based scientific overview of Mazdutide (IBI362), evaluating its dual GLP-1 and glucagon receptor co-agonism across in-vitro, preclinical, and h

Read more Mazdutide (IBI362): Mechanisms, Clinical Data, and Metabolic Profile of Dual GLP-1/Glucagon Receptor Agonism

Posted on by

Survodutide (BI 456906): Dual GLP-1/Glucagon Receptor Agonist in Metabolic and MASH Research

3D scientific illustration of Survodutide dual GLP-1 and glucagon receptor agonist interaction

Survodutide is a dual GLP-1 and glucagon receptor agonist demonstrating potent efficacy across clinical trials for obesity, metabolic dysfunction, and stea

Read more Survodutide (BI 456906): Dual GLP-1/Glucagon Receptor Agonist in Metabolic and MASH Research